Stryker completes Novadaq Technologies acquisition: 3 insights

Mackenzie Garrity -   Print  |

Stryker finalized its Novadaq Technologies acquisition for $701 million. They announced plans to purchased Novadaq Technologies in June.

Here are three insights:


1. Novadaq Technologies develops fluorescent imaging technology for blood flow visualization in vessels and tissue perfusion related to cardiac, cardiovascular, gastrointestinal, plastic, microsurgical and reconstructive procedures.


2. The transaction is expected to be dilutive to Stryker's 2017 adjusted net earnings per diluted share by $0.03 to $0.05.


3. In the agreement, Stryker paid $11.75 per share, with a net purchasing price of $654 million and nearly $47 million cash, totaling approximately $701 million.



Copyright © 2021 Becker's Healthcare. All Rights Reserved. Privacy Policy. Cookie Policy. Linking and Reprinting Policy.

Featured Webinars

Featured Whitepapers

Featured Podcast